A recent population-based study found that FTD at diagnosis was present in 10% of patients with ALS who underwent genetic analysis; the vast majority of cases (> 70%) did not carry genetic mutations, whereas 23% had C9orf72 expansion and 2% FUS mutation. This evidence concerns the gene C9orf72 and amyotrophic lateral sclerosis.